Table 2.

Predictors of HIV viral load non-suppression at 6 months among 215 ART naïve participants initiating ART, Dar es Salaam, Tanzania, 2019

Variable	Total	HIV non-suppression at 6 months n (%)	RR (95% CI)	Adjusted RR (95% CI)
Age (years)
<40	136	26 (19)	1	1
>40	79	20 (25)	1.32 (0.79 to 2.21)	1.43 (0.91 to 2.26)
Sex
Female	146	35 (24)	1.50 (0.81 to 2.78)	1.27 (0.73 to 2.20)
Male	69	11 (16)	1	1
Level of education
Primary or less	170	37 (22)	1
Secondary or higher	45	9 (20)	0.92 (0.48 to 1.76)
Employment status
Not employed	117	24 (21)	1
Employed	98	22 (22)	1.09 (0.66 to 1.83)
Marital status
Never married	113	19 (17)	1	1
Ever married	102	27 (26)	1.57 (0.93 to 2.66)	1.34 (0.84 to 2.16)
Body mass index
Change from baseline to 3 months
Loss >5%	28	17 (61)	4.93 (2.41 to 10.09)
Stable	122	21 (17)	1.40 (0.66 to 2.99)
Gain>5 %	65	8 (12)	1
Change from baseline to 6 months
Loss >5%	20	16 (80)	7.11 (3.69 to 13.69)	2.73 (1.36 to 5.47)
Stable	115	21 (18)	1.62 (0.78 to 3.36)	1.87 (0.95 to 3.68)
Gain>5 %	80	9 (11)	1	1
HIV clinical stage
I	133	24 (18)	1	1
II	30	8 (27)	1.48 (0.74 to 2.97)	1.14 (0.63 to 2.08)
III and IV	52	14 (27)	1.49 (0.84 to 2.66)	0.82 (0.51 to 1.31)
Total lymphocyte count change from baseline to 6 months
Ended lymphopaenic	37	27 (73)	7.66 (4.32 to 13.60)	4.54 (2.19 to 9.39)
Lymphopaenic to normal	52	7 (13)	1.41 (0.59 to 3.40)	1.59 (0.66 to 3.80)
Lymphopaenia not seen	126	12 (10)	1	1
Pattern of change in proteinuria
Proteinuria at 6 months regardless of baseline proteinuria status	37	24 (65)	6.73 (3.34 to 13.58)	2.63 (1.25 to 5.54)
Proteinuria at baseline and/or 3 months but not 6 months	95	14 (15)	1.53 (0.67 to 3.47)	1.26 (0.62 to 2.57)
No proteinuria seen	83	8 (10)	1	1

Univariable and multivariable analysis by modified Poisson regression.

ART, antiretroviral therapy; RR, relative risk.